We are monitoring the impact of COVID-19 on APAC Hematology Market Get in touch with us for detailed analysis Know More
Share on

Asia-Pacific Hematology Market Research Report - Segmented By Products, Application, End Users & Country (India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore and Rest of APAC) - Industry Analysis on Size, Share, Trends, COVID-19 Impact & Growth Forecast (2022 to 2027)

Published: January, 2022
ID: 1380
Pages: 182

APAC Hematology Market Size (2022 to 2027)

The Asia Pacific Hematology market size is estimated to grow at a high CAGR from 2022 to 2027.

The increasing incidence of blood disorders is one of the primary factors boosting the hematology market in the Asia Pacific region. Blood disorders are becoming heath issue worldwide and are also increasing the mortality rates of many countries. Furthermore, with the increase in population, blood disorders such as anemia, blood cancer, hemorrhagic conditions, and blood infections affect many people worldwide. As the Asia region is highly populated, blood disorders are being affected most and accelerating the market's growth in APAC.

Blood donation camps are increasing rapidly and increasing awareness in the people about the advantages of blood donations to society. This is increasing the demand for the Haematology market. As the elderly population is rising, growth in chronic diseases is rising, boosting the development of the market. New opportunities are being introduced with advancements in the technologies such as care testing devices. The government is also investing in the hematology market, driving the increase in the APAC Haematology Market. New low-cost diagnosis is introduced in this market that people are interested in and is expected to develop the market. 

However, a lack of awareness about blood donation in rural regions is hampering the market's growth. The major drawback of this market is the cost of installing is very high. The manufacturing and maintenance of the equipment cost are also very high. These factors are expected to be hampering the growth of the market. In addition, strict government rules in launching the new product and product recalls are further estimated to restrain the development of the market in the forecast period.

This research report on the Asia Pacific Hematology Market has been segmented and sub-segmented into the following categories:

By Product:

  • Hematology Analyzers
  • Hematology Reagents
  • Flow Cytometers
  • Hematology Cell Counters
  • Slide Stainers
  • Coagulation Analyzers
  • Hematology Testing
  • Centrifuges
  • Hemoglobinometers
  • Others

By Application:

  • Infectious Diseases
  • Cancer
  • Cardiovascular Disorders
  • Blood Screening
  • Diabetes
  • HIV
  • Auto-Immune Diseases

By End-User:

  • Hospitals
  • Clinics
  • Diagnostic Laboratories
  • Research and Development Centers
  • Others

By Country:

  • India
  • China
  • Japan
  • South Korea
  • Australia
  • New Zealand
  • Thailand
  • Malaysia
  • Vietnam
  • Philippines
  • Indonesia
  • Singapore
  • Rest of APAC

The key factors such as increasing investments by the government into the R&D department, increase in the use of automated hematology instruments in many laboratories, increase in the fast testing of hematology are rapidly accelerating the hematology market in the APAC and expected to position the APAC as the fastest-growing regional markets globally.

In the Asia Pacific region, China had the largest share in the APAC Hematology Market in 2020. The main driver for this market in China's increasing elderly population is growing chronic diseases that boost the growth of the market. Hematological testing became very important with the recent outbreak of COVID-19. As a result, the demand for hematology products has increased in various regions, which increased the need for the APAC Haematology Market.

Followed by China, Japan had the highest share in APAC Haematology Market. The new advancements in hematology analyzers with POC testing, rapid testing kits, new automation technologies are increasing the demand for the market. Globally in the hematology analyzers and reagents market, Japan is leading. Sysmex company is said to be leading in the supply of instruments and reagents in diagnostics. New research investments and new product launches are prominent in the future growth of the APAC Hematology market. These are the main factors behind the future development of the APAC Hematology Market.

KEY MARKET PLAYERS:

Companies playing a leading role in the Asia Pacific Hematology Market profiled in this report are Siemens AG Healthcare, Johnson & Johnson, Beckman Coulter, Inc., Abbott Laboratories, Thermo Fisher Scientific, Roche, HORIBA Ltd., Sysmex Corporation, Bio-Rad Laboratories Inc., Boule Diagnostics AB, Mindray Medical International Limited.

1.Introduction       

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods

                1.4 General Study Assumptions                

2. Research Methodology                

                2.1 Introduction   

                2.2 Research Phases                      

     2.2.1 Secondary Research            

     2.2.2 Primary Research 

     2.2.3 Econometric Modelling     

     2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview           

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology  

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)           

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market               

5. Market Segmentation                   

                5.1 Products                      

     5.1.1 Introduction           

     5.1.2 Hematology Analyzers       

                     5.1.2.1 Automated Analyzers

                     5.1.2.2 Semi-Automated Analyzers

     5.1.3 Hematology reagents         

                     5.1.3.1 Products

                     5.1.3.2 Consumables

     5.1.4 Flow cytomers      

     5.1.5 Hematology cell counters 

     5.1.6 Slide stainers         

     5.1.7 Coagulation Analyzers       

     5.1.8 Hematology testing             

     5.1.9 Centrifuges            

     5.1.10 Hemoglobinometers        

     5.1.11 Others   

     5.1.12 Y-o-Y Growth Analysis, By Products           

     5.1.13 Market Attractiveness Analysis, By Products          

     5.1.17 Market Share Analysis, By Products           

                5.2 Application                 

     5.2.1 Introduction           

     5.2.2 Infectious diseases              

     5.2.3 Cancer      

     5.2.4 Cardiovascular diseases    

     5.2.5 Blood Screening   

     5.2.6 Diabetes  

     5.2.7 HIV             

     5.2.8 Autoimmune disorders     

     5.2.9 Others      

     5.2.10 Y-o-Y Growth Analysis, By Application       

     5.2.11 Market Attractiveness Analysis, By Application     

     5.2.12 Market Share Analysis, By Application      

                5.3 End users                    

     5.3.1 Introduction           

     5.3.2 Hospitals  

     5.3.3 Clinics        

     5.3.4 Diagnostic Laboratories     

     5.3.5 Research and development centers             

     5.3.6 Others      

     5.3.7 Y-o-Y Growth Analysis, By End users             

     5.3.8 Market Attractiveness Analysis, By End usersd        

     5.3.9 Market Share Analysis, By End users            

6. Geographical Analysis                   

                6.1 Introduction   

     6.1.1 Regional Trends    

     6.1.2 Impact Analysis     

     6.1.3 Y-o-Y Growth Analysis        

                     6.1.3.1 By Geographical Area

                     6.1.3.2 By Products

                     6.1.3.3 By Application

                     6.1.3.4 By End users

     6.1.4 Market Attractiveness Analysis      

                     6.1.4.1 By Geographical Area

                     6.1.4.2 By Products

                     6.1.4.3 By Application

                     6.1.4.4 By End users

     6.1.5 Market Share Analysis        

                     6.1.5.1 By Geographical Area

                     6.1.5.2 By Products

                     6.1.5.3 By Application

                     6.1.5.4 By End users

                6.2 China 

                6.3 India   

                6.4 Japan 

                6.5 South Korea               

                6.6 Australia                      

7.Strategic Analysis             

                7.1 PESTLE analysis                         

     7.1.1 Political     

     7.1.2 Economic 

     7.1.3 Social         

     7.1.4 Technological         

     7.1.5 Legal          

     7.1.6 Environmental      

                7.2 Porter’s Five analysis   

     7.2.1 Bargaining Power of Suppliers        

     7.2.2 Bargaining Power of Consumers    

     7.2.3 Threat of New Entrants     

     7.2.4 Threat of Substitute Products and Services

     7.2.5 Competitive Rivalry within the Industry      

8.Market Leaders' Analysis               

                8.1 Siemens AG Healthcare                         

     8.1.1 Overview

     8.1.2 Product Analysis   

     8.1.3 Financial analysis  

     8.1.4 Recent Developments       

     8.1.5 SWOT analysis       

     8.1.6 Analyst View          

                8.2 Johnson & Johnson                 

                8.3 Beckman Coulter, Inc. 

                8.4 Abbott Laboratories               

                8.5 Thermo Fisher Scientific                        

                8.6 Roche

                8.7 HORIBA Ltd.               

                8.8 Sysmex Corporation               

                8.9 Bio-Rad Laboratories Inc.                      

                8.10 Boule Diagnostics AB

                8.11 Mindray Medical International Limited                        

9.Competitive Landscape                 

                9.1 Market share analysis 

                9.2 Merger and Acquisition Analysis                        

                9.3 Agreements, collaborations and Joint Ventures                          

                9.4 New Product Launches                          

10.Market Outlook and Investment Opportunities                

Appendix                

                a) List of Tables                

                b) List of Figures   

  1. Asia-Pacific Hematology Market, By Products, From 2022 - 2027 (USD Billion)
  2. Asia-Pacific Hematology Analyzers Market, By Region, From 2022 - 2027 (USD Billion)
  3. Asia-Pacific Hematology Reagents Market, By Region, From 2022 - 2027 (USD Billion)
  4. Asia-Pacific Flow Cytometers Market, By Region, From 2022 - 2027 (USD Billion)
  5. Asia-Pacific Hematology cell counters Market, By Region, From 2022 - 2027 (USD Billion)
  6. Asia-Pacific Slide Stainers Market, By Region, From 2022 - 2027 (USD Billion)
  7. Asia-Pacific Coagulation Analyzers Market, By Region, From 2022 - 2027 (USD Billion)
  8. Asia-Pacific Hematology Testing Market, By Region, From 2022 - 2027 (USD Billion)
  9. Asia-Pacific Centrifuges Market, By Region, From 2022 - 2027 (USD Billion)
  10. Asia-Pacific Hemoglobinometers Market, By Region, From 2022 - 2027 (USD Billion)
  11. Asia-Pacific Hematology Market, By Application, From 2022 - 2027 (USD Billion)
  12. Asia-Pacific Infectious diseases Market, By Region, From 2022 - 2027 (USD Billion)
  13. Asia-Pacific Cancer Market, By Region, From 2022 - 2027 (USD Billion)
  14. Asia-Pacific Cardiovascular disorders Market, By Region, From 2022 - 2027 (USD Billion)
  15. Asia-Pacific Blood Screening Market, By Region, From 2022 - 2027 (USD Billion)
  16. Asia-Pacific Diabetes Market, By Region, From 2022 - 2027 (USD Billion)
  17. Asia-Pacific HIV Market, By Region, From 2022 - 2027 (USD Billion)
  18. Asia-Pacific Autoimmune disorders Market, By Region, From 2022 - 2027 (USD Billion)
  19. Asia-Pacific Hematology Market, By End users, From 2022 - 2027 (USD Billion)
  20. Asia-Pacific Hospitals Market, By Region, From 2022 - 2027 (USD Billion)
  21. Asia-Pacific Clinics Market, By Region, From 2022 - 2027 (USD Billion)
  22. Asia-Pacific Diagnostic laboratories Market, By Region, From 2022 - 2027 (USD Billion)
  23. Asia-Pacific Research and development centers Market, By Region, From 2022 - 2027 (USD Billion)
  24. Japan Hematology Market, By Products, From 2022 - 2027 (USD Billion)
  25. Japan Hematology Market, By Application, From 2022 - 2027 (USD Billion)
  26. Japan Hematology Market, By End users, From 2022 - 2027 (USD Billion)
  27. China Hematology Market, By Products, From 2022 - 2027 (USD Billion)
  28. China Hematology Market, By Application, From 2022 - 2027 (USD Billion)
  29. China Hematology Market, By End users, From 2022 - 2027 (USD Billion)
  30. India Hematology Market, By Products, From 2022 - 2027 (USD Billion)
  31. India Hematology Market, By Application, From 2022 - 2027 (USD Billion)
  32. India Hematology Market, By End users, From 2022 - 2027 (USD Billion)
  33. Asia-Pacific Hematology Market, By Hematology Analyzers, From 2022 - 2027 (USD Billion)
  34. Asia-Pacific Automated Analyzers Market, By Region, From 2022 - 2027 (USD Billion)
  35. Asia-Pacific semi-automated analyzers Market, By Region, From 2022 - 2027 (USD Billion)
  36. Japan Hematology Market, By Hematology Analyzers, From 2022 - 2027 (USD Billion)
  37. China Hematology Market, By Hematology Analyzers, From 2022 - 2027 (USD Billion)
  38. India Hematology Market, By Hematology Analyzers, From 2022 - 2027 (USD Billion)
  39. Asia-Pacific Hematology Market, By Hematology Reagents, From 2022 - 2027 (USD Billion)
  40. Asia-Pacific Products Market, By Region, From 2022 - 2027 (USD Billion)
  41. Asia-Pacific Consumables Market, By Region, From 2022 - 2027 (USD Billion)
  42. Japan Hematology Market, By Hematology Reagents, From 2022 - 2027 (USD Billion)
  43. China Hematology Market, By Hematology Reagents, From 2022 - 2027 (USD Billion)
  44. India Hematology Market, By Hematology Reagents, From 2022 - 2027 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

PURCHASE OPTIONS

excel
$

3335


pdf excel
$

3680


pdf excel powerbi
$

5520


excel
$

2000

What You Get :

  • PDF Report Format.
  • Can be accessible by 1 single user.
  • 6 Months of Free Analyst Support.
  • PDF and Excel Datasheet Formats.
  • Can be accessible upto 2 to 5 users.
  • 1 Year of Free Analyst Support.
  • PDF, Excel and Power BI Dashboard.
  • Can be accessible by unlimited users.
  • 1 Year of Free Analyst Support.
  • Excel Datasheet Format.
  • Customized access as per user request.
  • Upgradable to other licenses.
customer-support
ASK FOR CUSTOMIZATION

Talk to our analyst and get customised report done according to your research needs

tag
INQUIRE FOR DISCOUNT

Check if you can avail any discount. Submit your details and our team will get back to you.

cloud-download
DOWNLOAD FREE SAMPLE

Request to avail a free sample report that reflects this market and its growth.

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 3335

Didn’t find what you’re looking for?
TALK TO OUR TEAM

Find it too expensive?
NO WORRIES!

Click for Request Sample